PharmaSGP Holding SE
XETRA:PSG
PharmaSGP Holding SE
Net Income (Common)
PharmaSGP Holding SE
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
PharmaSGP Holding SE
XETRA:PSG
|
Net Income (Common)
€12m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Net Income (Common)
-$40.2m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bayer AG
XETRA:BAYN
|
Net Income (Common)
-€2.9B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Net Income (Common)
€2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
9%
|
|
MPH Health Care AG
XETRA:93M1
|
Net Income (Common)
€29.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Net Income (Common)
€62.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
See Also
What is PharmaSGP Holding SE's Net Income (Common)?
Net Income (Common)
12m
EUR
Based on the financial report for Dec 31, 2022, PharmaSGP Holding SE's Net Income (Common) amounts to 12m EUR.
What is PharmaSGP Holding SE's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
0%
Over the last year, the Net Income (Common) growth was 12%. The average annual Net Income (Common) growth rates for PharmaSGP Holding SE have been -11% over the past three years .